Founder Directory
Built by Keitoto
Founders3
Known for these resultsRole67%Role is parsed from founder titles in yc.db. Known for 67% of these rows — the rest have no title at all, mostly 2019–2023. Those rows stay in the result and are counted as Unknown, never as No.Bio100%Bio coverage: 100% of these founders have a bio on their YC profile. Every bio-derived facet (ex-company, school, credentials, discipline) is Unknown for the rest.Ex-company33%Ex-company is matched from bios with employment context (ex-, formerly, worked at). 33% of these rows have at least one match.School33%School is matched from bios, case-sensitive for acronyms. 33% of these rows have at least one match.
- Oded Falik@_odedfFounder/CTO · Strand AIW26Healthcare · San Francisco
- Yue DaiFounder/CEO · Strand AIW26Healthcare · San Francisco
- Hari BhaskaranFounder · Cisterna BiologicsS22Healthcare · San Diego
FOUNDERROLEBATCHINDUSTRYLOCATIONTEAMX_url
Oded FalikStrand AIFounder/CTOWinter 2026HealthcareSan Francisco, United States2https://x.com/_odedfYue DaiStrand AIFounder/CEOWinter 2026HealthcareSan Francisco, United States2—Hari BhaskaranCisterna BiologicsFounderSummer 2022HealthcareSan Diego, United States2—Showing 1–3 of 3 founders
Hari Bhaskaran
Founder·Cisterna Biologics
PRIMARY INFO
RoleFounder· not in title
Team size2
BatchSummer 2022
LocationSan Diego, United States
Company statusActive
StageEarly
BIO
Hari Bhaskaran's journey with RNAs started with ribozymes (catalytic RNAs) almost 20 years ago in the labs of Rick Russell at UT Austin. His PhD work was focused on mechanistic understanding of RNA folding, culminating in a seminal publication in Nature (see Bhaskaran and Russell, 2007). Since then, he has held positions of increasing responsibilities in both academia and industry. He is the author of several publications and industry patents.
Ex-company, school and discipline below are derived from this bio. Nothing is inferred when the bio is missing.
BACKGROUND
CredentialsPhD
DisciplineResearcherKeyword match from the bio text, not a classifier.
TRACK RECORD
First YC company on record
COMPANY CONTEXT
High quality mRNA for therapeutic application